A SARS-CoV-2 targeted siRNA-nanoparticle therapy for COVID-19.
Idris A, Davis A, Supramaniam A, Acharya D, Kelly G, Tayyar Y, West N, Zhang P, McMillan CLD, Soemardy C, Ray R, O'Meally D, Scott TA, McMillan NAJ, Morris KV.
Idris A, et al. Among authors: ray r.
bioRxiv [Preprint]. 2021 Apr 19:2021.04.19.440531. doi: 10.1101/2021.04.19.440531.
bioRxiv. 2021.
PMID: 33907744
Free PMC article.
Updated.
Preprint.